These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32859086)

  • 21. The vascular phenotype in Pseudoxanthoma elasticum and related disorders: contribution of a genetic disease to the understanding of vascular calcification.
    Lefthériotis G; Omarjee L; Le Saux O; Henrion D; Abraham P; Prunier F; Willoteaux S; Martin L
    Front Genet; 2013; 4():4. PubMed ID: 23408347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversion of arterial calcification by elastin-targeted DTPA-HSA nanoparticles.
    Keuth J; Nitschke Y; Mulac D; Riehemann K; Rutsch F; Langer K
    Eur J Pharm Biopharm; 2020 May; 150():108-119. PubMed ID: 32151731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bruch's Membrane Calcification in Pseudoxanthoma Elasticum: Comparing Histopathology and Clinical Imaging.
    Risseeuw S; Pilgrim MG; Bertazzo S; Brown CN; Csincsik L; Fearn S; Thompson RB; Bergen AA; Ten Brink JB; Kortvely E; Spiering W; Ossewaarde-van Norel J; van Leeuwen R; Lengyel I
    Ophthalmol Sci; 2024; 4(2):100416. PubMed ID: 38170125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of Inflammation and Calcification in Pseudoxanthoma Elasticum Arteries and Skin with 18F-FluroDeoxyGlucose and 18F-Sodium Fluoride Positron Emission Tomography/Computed Tomography Imaging: The GOCAPXE Trial.
    Omarjee L; Mention PJ; Janin A; Kauffenstein G; Pabic EL; Meilhac O; Blanchard S; Navasiolava N; Leftheriotis G; Couturier O; Jeannin P; Lacoeuille F; Martin L
    J Clin Med; 2020 Oct; 9(11):. PubMed ID: 33120982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of pseudoxanthoma elasticum on the lipid profile and prognostic implications.
    Stumpf MJ; Winkler T; Siebigteroth M; Lenzen A; Weinhold L; Nickenig G; Hendig D; Skowasch D; Schahab N; Schaefer CA
    Vasa; 2024 Jul; ():. PubMed ID: 39017644
    [No Abstract]   [Full Text] [Related]  

  • 26. Plasma lipids in Pseudoxanthoma Elasticum (PXE) patients: A comparative study with population-based reference values and Non-PXE controls.
    Harmsen IM; Visseren FLJ; Kok M; de Jong PA; Spiering W
    Atheroscler Plus; 2024 Mar; 55():5-11. PubMed ID: 38221909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships between Plasma Pyrophosphate, Vascular Calcification and Clinical Severity in Patients Affected by Pseudoxanthoma Elasticum.
    Leftheriotis G; Navasiolava N; Clotaire L; Duranton C; Le Saux O; Bendahhou S; Laurain A; Rubera I; Martin L
    J Clin Med; 2022 May; 11(9):. PubMed ID: 35566717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum Calcification Propensity T50 Associates with Disease Severity in Patients with Pseudoxanthoma Elasticum.
    Nollet L; Van Gils M; Fischer S; Campens L; Karthik S; Pasch A; De Zaeytijd J; Leroy BP; Devos D; De Backer T; Coucke PJ; Vanakker OM
    J Clin Med; 2022 Jun; 11(13):. PubMed ID: 35807012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyrophosphates as a major inhibitor of matrix calcification in Pseudoxanthoma elasticum.
    Dabisch-Ruthe M; Kuzaj P; Götting C; Knabbe C; Hendig D
    J Dermatol Sci; 2014 Aug; 75(2):109-20. PubMed ID: 24907773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skin and Arterial Wall Deposits of 18F-NaF and Severity of Disease in Patients with Pseudoxanthoma Elasticum.
    Gutierrez-Cardo A; Lillo E; Murcia-Casas B; Carrillo-Linares JL; García-Argüello F; Sánchez-Sánchez P; Rodriguez-Morata A; Aranda IB; Sánchez-Chaparro MÁ; García-Fernández M; Valdivielso P
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32397252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The amount of calcifications in pseudoxanthoma elasticum patients is underestimated in computed tomographic imaging; a post-mortem correlation of histological and computed tomographic findings in two cases.
    Vos A; Kranenburg G; de Jong PA; Mali WPTM; Van Hecke W; Bleys RLAW; Isgum I; Vink A; Spiering W
    Insights Imaging; 2018 Aug; 9(4):493-498. PubMed ID: 29858817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma inorganic pyrophosphate and alkaline phosphatase in patients with pseudoxanthoma elasticum.
    Sánchez-Tévar AM; García-Fernández M; Murcia-Casas B; Rioja-Villodres J; Carrillo JL; Camacho M; Van Gils M; Sánchez-Chaparro MA; Vanakker O; Valdivielso P
    Ann Transl Med; 2019 Dec; 7(24):798. PubMed ID: 32042814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunochemical identification of abnormal constituents in the dermis of pseudoxanthoma elasticum patients.
    Baccarani-Contri M; Vincenzi D; Cicchetti F; Mori G; Pasquali-Ronchetti I
    Eur J Histochem; 1994; 38(2):111-23. PubMed ID: 7524808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pseudoxanthoma elasticum with prominent arterial calcifications evoking CD73 deficiency.
    Devriese M; Legrand A; Courtois MC; Jeunemaitre X; Albuisson J
    Vasc Med; 2019 Oct; 24(5):461-464. PubMed ID: 31164056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Plasma Pyrophosphate Cutoff Value for Diagnosing Pseudoxanthoma Elasticum.
    Rubera I; Clotaire L; Laurain A; Destere A; Martin L; Duranton C; Leftheriotis G
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of plasma fetuin-a levels with peripheral arterial disease and lower extremity arterial calcification in subjects with type 2 diabetes mellitus.
    Eleftheriadou I; Grigoropoulou P; Kokkinos A; Mourouzis I; Perrea D; Katsilambros N; Sfikakis PP; Tentolouris N
    J Diabetes Complications; 2017 Mar; 31(3):599-604. PubMed ID: 27899247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arterial calcifications in beta-thalassemia.
    Aessopos A; Samarkos M; Voskaridou E; Papaioannou D; Tsironi M; Kavouklis E; Vaiopoulos G; Stamatelos G; Loukopoulos D
    Angiology; 1998 Feb; 49(2):137-43. PubMed ID: 9482513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variants in genes encoding pyrophosphate metabolizing enzymes are associated with Pseudoxanthoma elasticum.
    Dabisch-Ruthe M; Brock A; Kuzaj P; Charbel Issa P; Szliska C; Knabbe C; Hendig D
    Clin Biochem; 2014 Oct; 47(15):60-7. PubMed ID: 25025693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical presentation of pseudoxanthoma elasticum with abdominal cutis laxa: evidence for a spectrum of ectopic calcification disorders?
    Vanakker OM; Leroy BP; Schurgers LJ; Vermeer C; Coucke PJ; De Paepe A
    Am J Med Genet A; 2011 Nov; 155A(11):2855-9. PubMed ID: 21964806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ankle--brachial index and the diabetic foot: a troublesome marriage.
    Aerden D; Massaad D; von Kemp K; van Tussenbroek F; Debing E; Keymeulen B; Van den Brande P
    Ann Vasc Surg; 2011 Aug; 25(6):770-7. PubMed ID: 21514102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.